Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Genetics and epigenetics

Subspecialties Hematology

A Walk on the Hemato-Path

| George Francis Lee | 3 min read

A brisk jog through some of hematopathology’s most interesting research stories

Subspecialties Oncology

Rapid, Reliable Results

| Sponsored by Thermo Fisher Scientific | 4 min read

Lung cancer patients can’t always wait for treatment – so rapid in-house NGS can facilitate precision therapy fast

Diagnostics Omics

A Rare Disease Revolution

| Stephen Kingsmore | 15 min read

Rapid, reliable, widespread whole genome sequencing could shorten the rare disease diagnostic odyssey and improve patients’ lives

Diagnostics Oncology

The Hype Over HRD Testing

| Liv Gaskill | 3 min read

Homologous recombination deficiency is a crucial predictive biomarker in certain cancer types – and it’s time to get on board

Diagnostics Genetics and epigenetics

Growth in Cancer Genetics

| George Francis Lee | 2 min read

The world of cancer genetics is getting bigger… so we bring you the latest news and research in molecular oncology

Subspecialties Oncology

Chronic Cancer Queries

| George Francis Lee | 2 min read

Like the progression of the disease itself, the growth of knowledge around chronic lymphocytic leukemia is slow, but steady

Diagnostics Genetics and epigenetics

Covering All Bases

| Sponsored by QIAGEN | 6 min read

The need for molecular testing in NSCLC patients is growing – and QIAGEN can help you meet it

Diagnostics Genetics and epigenetics

The Genes of the Spectrum

| George Francis Lee | 2 min read

How is current research mapping a fuller picture of the autism spectrum?

Subspecialties Oncology

Insights into Cancer Inequalities

| Georgia Hulme | 2 min read

Investigating ethnic disparities in esophageal adenocarcinoma and prostate cancer

Subspecialties Oncology

Unraveling the Complexity of Intratumor Heterogeneity

| George Francis Lee | 2 min read

How advances in our understanding of intratumor heterogeneity (ITH) may lay a path for new clinical applications

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register